— Know what they know.
Not Investment Advice
Also trades as: COH.AX (ASX) · $vol 53M · CHEOF (OTC) · $vol 0M

CHEOY OTC

Cochlear Limited
1W: -12.7% 1M: -10.9% 3M: -1.9% YTD: -50.0% 1Y: -53.0% 3Y: -44.9% 5Y: -43.3%
$43.58
-1.71 (-3.77%)
 
Weekly Expected Move ±5.9%
$38 $41 $44 $46 $49
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 43 · $5.7B mcap · 65M float · 0.099% daily turnover · Short 7% of daily vol

Cash Flow Trends

Operating Cash Flow
$368M +54.9% ▲
5Y CAGR: +6.8%
Capital Expenditures
$91M +11.6% ▲
5Y CAGR: +6.3%
Free Cash Flow
$277M +105.4% ▲
5Y CAGR: +6.9%
Dividends Paid
$281M -1.1% ▼
Buybacks
$100K +99.6% ▲
Net Change in Cash
-$88M +63.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$289M$301M$0$0$0
Depreciation & Amort.$73M$81M$0$0$0
Stock-Based Comp.$11M$16M$0$0$0
Change in Working Capital-$23M-$28M-$107M$0-$30M
Other Non-Cash Items-$18M$7M$496M$238M$398M
Operating Cash Flow$376M$362M$389M$238M$368M
— Investing Activities —
Capital Expenditures-$77M-$96M-$62M-$62M-$61M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$62M-$30M-$16M-$13M-$14M
Investment Sales$0$0$0$0$0
Other Investing-$94M-$76M-$27M-$40M-$30M
Investing Cash Flow-$139M-$126M-$106M-$115M-$104M
— Financing Activities —
Net Debt Issuance-$26M-$41M$0$0$0
Stock Repurchased$0-$30M-$43M-$28M-$100K
Dividends Paid-$194M-$197M-$246M-$278M-$281M
Other Financing$0-$42M-$35M-$60M-$63M
Financing Cash Flow-$221M-$310M-$324M-$367M-$344M
Net Change in Cash$20M-$74M-$42M-$238M-$88M
Cash End of Period$629M$556M$514M$276M$188M
Free Cash Flow$299M$266M$299M$135M$277M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms